Efficacy, safety and patient reported outcomes in patients with active relapsing multiple sclerosis treated with ocrelizumab: Final results from the PRO-MSACTIVE study
- Resource Type
- Review Article
- Source
- In
Multiple Sclerosis and Related Disorders December 2022 68 - Subject
- Language
- ISSN
- 2211-0348